Year: 2022

Invest Bank will be one of the first in UAE to run digital and core banking on a SaaS platform GENEVA, Nov. 16, 2022 (GLOBE NEWSWIRE) — Invest Bank, a premier commercial bank in UAE, has selected Temenos (SIX: TEMN) to take its digital and core banking to the cloud, in partnership with NdcTech. Invest Bank will adopt an end-to-end retail and wholesale banking solution on the Temenos Banking Cloud, becoming one of the first in the UAE to adopt a full SaaS model for its digital and core banking platform. The front-to-back capabilities of Infinity and Transact delivered as SaaS on Temenos’ open platform for composable banking will enable Invest Bank to modernize legacy platforms, bring new products and services to market faster, as well as deliver more innovative customer experiences. Planned enhancements include instant onboarding...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.   Oslo, 16 November 2022. IDEX Biometrics ASA (the “Company“), a leading provider of advanced fingerprint identification and authentications solutions, has retained ABG Sundal Collier ASA and Arctic Securities AS as Joint Bookrunners (the “Managers“) to advise on and effect a private placement (the “Private Placement“) of new shares in the Company (the “Offer Shares“) to raise gross proceeds of up to the NOK equivalent of USD 15 million. The net proceeds from the Private Placement will be used to build further momentum for the Company’s commercial ramp-up,...

Conference call to follow on November 22, 2022 at 9:00am ET NEW YORK, Nov. 16, 2022 (GLOBE NEWSWIRE) — StoneX Group Inc. (NASDAQ: SNEX) today announced that it will release its fiscal 2022 fourth quarter results after the market close on Monday, November 21, 2022. Management will host a conference call on Tuesday, November 22, 2022 at 9:00 a.m. Eastern Time to review the Company’s 2022 fiscal fourth quarter results. A live web cast of the conference call as well as additional information to review during the call will be made available in PDF form at https://www.stonex.com. Participants can also access the call via https://register.vevent.com/register/BIc54c02e6ccf34bb6b56bafdef3029edc approximately ten minutes prior to the start time. Participants may preregister for the conference call here. For those who cannot access...

Wednesday, 16 November 2022 | SAINT HELIER, Jersey – The Board of CoinShares International Limited (“CoinShares” or the “Company“) (Nasdaq First North Growth Market: CS; US OTCQX: CNSRF), Europe’s largest digital asset investment firm, has today resolved to cancel 78,396 treasury shares, which were acquired through share buy-backs up to 22 September 2022. The cancellation of own shares will be registered with Euroclear Sweden and the Company’s Registrar as soon as possible and, in any event, before 30 November 2022. After the cancellation, the total number of shares in CoinShares will be 68,135,425 and the total number of votes attached to the shares will be 68,135,425. Following registration of the cancellation, the Company will hold no treasury shares. About CoinShares CoinShares is Europe’s largest...

Citrine Global, Corp. GreenFeelsTM product lines and brand Company also Announces the Introduction of GreenFeelsTM Product Lines Tel Aviv, Nov. 16, 2022 (GLOBE NEWSWIRE) — Citrine Global Corp. (OTCQB: CTGL) is pleased to announce that the Company’s subsidiary has filed a provisional patent application in the United States Patent and Trademark Office (USPTO) for “COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, ALLEVIATING, MITIGATING OR BALANCING SIDE-EFFECTS ASSOCIATED WITH THE USE OF MEDICINES, TREATMENTS, AGING, AND UNBALANCED OR UNHEALTHY LIFESTYLE”, patent No: 63/418,046. The patent application relates to compositions, methods and solutions for balancing side effects caused by medicinal use, medical treatments, aging and unbalanced or unhealthy lifestyle, such as dryness in the oral cavity, headaches, dizziness, drowsiness,...

CRO Marty Grunst will assume CFO role, Mindy Mahaney stepping up as next CRO TULSA, Okla., Nov. 16, 2022 (GLOBE NEWSWIRE) — BOK Financial announced that Chief Financial Officer Steven Nell will retire effective March 31, 2023, after 30 years with the company and more than 20 years as CFO. Upon his retirement, Chief Risk Officer Marty Grunst will become the company’s next CFO. “Steven’s expertise and stewardship have been important to BOK Financial’s growth during his tenure with the company,” said Stacy Kymes, president and chief executive officer of BOK Financial. “We are tremendously grateful to Steven for his contributions to our company, but this transition is made easier by Marty’s considerable financial management experience, as well as his strategic and operational savvy. He will be a tremendous asset as we navigate a complex...

OSLO, Norway, Nov. 16, 2022 (GLOBE NEWSWIRE) — Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced it will report its financial results for the third quarter of 2022 on November 23, 2022 before market open and subsequently host a webcast presentation at 4 p.m. CET / 10 a.m. ET. A live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website: https://nykode.com/investors/financial-reports-and-presentations. About Nykode TherapeuticsNykode Therapeutics is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies for the treatment of cancer and infectious diseases. Nykode’s modular vaccine technology specifically targets...